Fluorofenidone Attenuates Renal Interstitial Fibrosis by Enhancing Autophagy and Retaining Mitochondrial Function

BACKGROUND

Fluorofenidone (AKF-PD) is a novel pyridone agent and has potent anti-NLRP3 inflammasome and anti-fibrotic activities. However, the mechanisms underlying its pharmacological actions are not fully understood.

METHODS

A renal fibrosis rat model was established by the unilateral ureteral obstruction (UUO) procedure and the rats were randomized and treated with, or without, AKF-PD for 3 and 7 days. The levels of renal fibrosis, NLRP3 inflammasome activation, mitochondrial function, and autophagy were tested in rat kidney tissues. Macrophages following lipopolysaccharides (LPS) and adenosine 5'-triphosphate (ATP) stimulation were examined by Western blot, spectrophotometry, and TEM.

RESULTS

Compared with the untreated UUO rats, AKF-PD treatment significantly mitigated the UUO procedure-induced renal fibrosis in rats. AKF-PD treatment decreased mitochondrial dysfunction and IL-Iβ and caspase-1 expression in rat kidney tissues and reduced mitochondrial reactive oxygen species production in activated macrophages. Mechanistically, AKF-PD treatment significantly attenuated the PI3K/AKT/mTOR signaling, increased Beclin-1 and LC3 II expression and autophagosome formation, and ameliorated the mitochondrial damage in renal tissues and activated macrophages.

CONCLUSION

The results indicated that AKF-PD treatment inhibited renal interstitial fibrosis by regulating the autophagy-mitochondria-NLRP3 inflammasome pathway.

Sensitivity analysis of operation parameters of the salt cavern under long-term gas injection-production

Injection-production operation parameters, the minimum injection gas pressure (IGP: operation pressure), IGP interval, minimum IGP residence time, and injection-production cycle of the underground salt rock gas storage under long-term operation, affect not only the capacity and working ability of a salt cavern but also be crucial to the safety and stability of the surrounding rock. A 3D geo-mechanical model of the salt cavern is established to study the stability of the storage in the operation period. The deformation, expansion safety factor, volume shrinkage, and plastic zone are comprehensively considered for predicting the feasibility and stability of the salt cavern. The stability of the surrounding rock of the cavern with different injection-production parameters and the impact of each parameter on the stability of the cavern during operating are systematically investigated. The results indicate that the displacement, the expansion coefficient of the surrounding rock, and the volume shrinkage rate of the salt cavern reduces significantly with the increment of IGP interval and minimum IGP, while they increases with raising the minimum IGP residence time and injection-production cycle. With the continuous operation of the cavity, the displacement and the volume shrinkage rate enhances significantly year by year with the augment of operation parameters, moreover, their value show a fluctuating upward trend with the alternation of the gas injection and the production. The volume of the plastic zone is enlarged with the increment of the IGP interval, minimum IGP, and injection-production cycle, while it reduces with the extension of the minimum IGP residence time. The variation becomes remarkably with the augment of parameters. The sensitivity coefficients of each injection-production operation parameter are ranked, from large to small, as follows: IGP interval, minimum IGP, minimum IGP residence time, injection-production cycle. The results can offer beneficial reference for effectively optimize the injection-production parameters, so as to provide technical guidance for ensuring the stability of the storage and meeting requirements for the storage capacity.

Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization

The tumor vasculature was different from the normal vasculature in both function and morphology, which caused hypoxia in the tumor microenvironment (TME). Previous anti-angiogenesis therapy had led to a modest improvement in cancer immunotherapy. However, antiangiogenic therapy only benefitted a few patients and caused many side effects. Therefore, there was still a need to develop a new approach to affect tumor vasculature formation. The CD93 receptor expressed on the surface of vascular endothelial cells (ECs) and its natural ligands, MMRN2 and IGFBP7, were now considered potential targets in the antiangiogenic treatment because recent studies had reported that anti-CD93 could normalize the tumor vasculature without impacting normal blood vessels. Here, we reviewed recent studies on the role of CD93, IGFBP7, and MMRN2 in angiogenesis. We focused on revealing the interaction between IGFBP7-CD93 and MMRN2-CD93 and the signaling cascaded impacted by CD93, IGFBP7, and MMRN2 during the angiogenesis process. We also reviewed retrospective studies on CD93, IGFBP7, and MMRN2 expression and their relationship with clinical factors. In conclusion, CD93 was a promising target for normalizing the tumor vasculature.